Actemra Binding Assays

BioOutsource has extensive experience in the development, optimization and qualification of a wide range of different types of binding assays and immunoassays, and offers GLP and cGMP-compliant testing services in compliance with EMA and FDA guidelines to support the biopharmaceutical industry.

Using this experience, we have created a range of biosimilar off-the-shelf binding assays. Binding assays are employed to study a number of different features of Actemra/RoActemra (tocilizumab) and play a vital role in the development process, and characterization and comparability of biosimilar molecules.  BioOutsource offer the following assays to support the characterization of Actemra (tocilizumab):

BioOutsource offers cost-effective solutions to develop custom methods that are not currently in our portfolio; please contact us to find out more.